Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry Advocacy Group Goes Global After Device Tax Repeal

Jan 27 2020

• By Ferdous Al-Faruque

AdvaMed’s Scott Whitaker — AdvaMed CEO Scott Whitaker spoke with Medtech Insight at his Washington, DC, office about the group's 2020 agenda. • Source: Ferdous Al-Faruque

Related Content

Crossing The 'Valley Of Death': Breakthrough Devices Rule Could Lead To Slew Of New Products

Apr 24 2019

CMS Clarifies Criterion To Evaluate New Tech Add-On Payments In Inpatient Rule

Aug 08 2019

FDI In India’s Medical Devices Sector Plunges, Experts Blame Price Controls

May 22 2019

Trump Signs Bill Bolstering US FDA Device Center Funding By 2% To $8M

Dec 23 2019

US Senate Sponsors Push Back Vote On Balanced Billing Legislation To Autumn

Jul 25 2019

US Trade Representative Removes Host Of Devices, Parts From China Tariff List

Jul 11 2019

Medtech Industry Groups Spend Millions In 2019 Lobbying For Device-Tax Repeal – And Much More

Oct 02 2019

US FDA Toying With Idea Of ‘Regulatory Legos’ In MDUFA V

Oct 01 2019

AdvaMed Chair: Another Device Tax Moratorium More Likely Than A Full Repeal

Sep 24 2019

Real-World Evidence User-Fee Funding Praised At FDA Meeting

Nov 02 2016

MDIC Snags $3m For FDA Real-World Evidence Coordinating Center

Sep 13 2016

Podcast: US FDA Experts Caution Against Banning EtO, Encourage More Duodenoscope Training

Nov 09 2019

Additional Topics

United States China Asia Pacific India Brazil South America Japan Regulation Policy FDA Government Payers Legislation Lobbying Manufacturing Politics Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.